Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Apr 2026 for Capricor Therapeutics, INC., €21k.
Filing timeline
BuySaleKarimah Es Sabar
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Karimah Es Sabar: trading record in brief
This profile gathers the share dealings of Karimah Es Sabar in Capricor Therapeutics, Inc. Over a trading history stretching from 31 March 2026 to 2 April 2026, the count stands at 6 filings.
No open-market purchase appears, only 3 sales worth €3.2M. The rest of the record consists of 3 option exercises.
The latest filing, published on 3 April 2026, reports an option exercise of €21k in Capricor Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karimah Es Sabar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
7,529 shares@ US$3.180.6% of flowCommon StockSEC:0001873796-26-000006:0
7,529 shares@ US$32.005.6% of flowCommon StockSEC:0001873796-26-000006:1
61,265 shares@ US$4.866.9% of flowCommon StockSEC:0001873796-26-000004:0
61,265 shares@ US$30.16842.6% of flowCommon StockSEC:0001873796-26-000004:1
53,735 shares@ US$4.866.0% of flowCommon StockSEC:0001873796-26-000004:2
53,735 shares@ US$31.026838.4% of flowCommon StockSEC:0001873796-26-000004:3
6 of 6 declarations
